☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
$170M
GSK Signs a Synthetic Lethality Cancer Agreement with Ideaya for ~$170M
June 17, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.